Adenosine Receptor

Adenosine Receptor

Adenosine receptors (ARs) comprise a group of G protein-coupled receptors (GPCR) which mediate the physiological actions of adenosine. Four AR subtypes have so far been cloned and found in various tissues. When exposed to agonists, these receptors exhibit unique localization, signal transduction pathways, and modes of regulation. The capacity of some Adenosine receptors to act as sensors of cellular oxidative stress, which is transmitted by transcription factors like NF-B to control the expression of ARs, is one of their key characteristics. We'll look at the role of adenosine receptors in the control of healthy and unhealthy processes, including sleep, the growth of cancer, and the prevention of hearing loss.

Adenosine Receptor related products

Structure Cat No. Product Name CAS No. Product Description
V81844 1-Bromo-6-chlorohexane 6294-17-3 1-Bromo-6-chlorohexane is a PROTAC (PROteolysis TArgeting Chimera) linker that may be utilized to prepare PROTAC.
V30762 5'-N-Ethylcarboxamidoadenosine 35920-39-9 NECA (5'-N-Ethylcarboxamidoadenosine) is a novel and potent adenosine receptor agonist with Ki values of 6.2, 14, and 20 nM for human A3, A1 and A2A receptors, respectively, and an EC50 of 2.4 μM for human A2B.
V75274 A1/A3 AR antagonist 1 312929-49-0 A1/A3 AR antagonist 1 (compound 10) is a potent dual antagonist of adenylate 1 (A1) and adenylate 3 (A3) receptors, with Ki for human A1, human A3 and rat A1 respectively.
V75268 A1/A3 AR antagonist 3 2665804-57-7 A1/A3 AR antagonist 3 is a dual A1R/A3R antagonist (inhibitor) with high affinity in the low micromolar to low nanomolar range.
V75271 A1AR antagonist 1 2760128-99-0 A1AR antagonist 2 (compound 18g) is a potent and specific A1 adenosine receptor antagonist (inhibitor) with Ki of 2.08, 6.91 and 31.2 nM for hA1, hA2A and hA2B respectively.
V3128 A2A receptor antagonist 1 443103-97-7 A2A receptor antagonist 1 is a novel and potent antagonist of the adenosine A2A receptor and A1 receptor with Kis of 4 and 264 nM, respectively.
V51754 A2A receptor antagonist 2 2767206-20-0 A2A receptor antagonist 2 (compound 57) is a potent and selective adenosine A2A receptor antagonist (inhibitor) with IC50 of 8.3 nM.
V80161 A2AAR antagonist 2 3′-Methoxyfurano[4″,5″:3,4]chalcone (compound 2) is a selective A2AAR antagonist (IC50=33.5 nM) with high affinity.
V51753 A2AR-antagonist-1 2922920-71-4 A2AR-antagonist-1 (compound 38) is a potent cervical adenylate A2A receptor (A2AR) clamp antagonist (IC50=29 nM).
V75263 A2B receptor antagonist 2 784-90-7 A2B receptor antagonist 2 (compound 18) is an antagonist of the adenosine receptor A2B, with Kis of 2.30 μM, 6.8 μM and 3.44 μM for rA1, rA2A and hA2B, respectively.
V78476 A3AR agonist 1 A3AR agonist 1 (Compound 12) is an A3AR agonist (Ki: 25.8 nM).
V77938 A3AR agonist 2 A3AR agonist 2 (Compound 19) is a selective A3AR agonist (Ki: 22.1 nM).
V75278 A3AR antagonist 2 1144161-05-6 A3AR antagonist 2 (compound 18) is a potent human A3 adenosine receptor blocker (antagonist) with Ki of 4.54 nM.
V79210 A3AR modulator 1 A3AR modulator 1 (MRS8054) is an orally bioactive A3AR (Adenosine Receptor) PAM (positive allosteric modulator).
V3126 Acefylline 652-37-9 Acefylline (also known as Theophylline-7-acetic acid and Theophyllineacetic acid), is an antagonist of theadenosine receptor and an activator of the peptidylarginine deiminase (PAD).
V10332 Adenosine 58-61-7 Adenosine is an endogenous nucleoside consisting of an adenine attached via a β-N₉-glycosidic bond to a ribose.
V75275 Adenosine 5'-monophosphate disodium (5'-Adenine nucleotide disodium salt (5'-AMP-NA2)) 4578-31-8 Adenosine 5'-monophosphate disodium is an orally bioactive purine nucleotide involved in ATP metabolism.
V51755 Adenosine receptor antagonist 1 2682930-40-9 Adenosine receptor antagonist 1 A2aR-selective antagonist that is 14 times more selective for A2aR than A2bR with an IC50 of 0.29 nM.
V75269 Adenosine receptor antagonist 4 133240-06-9 Adenosine receptor antagonist 4 (compound 2) is an adenosine A1 receptor antagonist (inhibitor) with a Ki of 101 nM for the human A1 receptor.
V3437 BAY-545 1699717-32-2 BAY-545 is a novel, potent and selective antagonist of A2B adenosine receptor with an IC50 of 59 nM.
Contact Us Back to top